FindTrial
Sign In

Differences of gastric mucosa-associated microbiota between patients with bile reflux gastritis and healthy people

Differences of gastric mucosa-associated microbiota between patients with bile reflux gastritis and healthy people

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050794
Enrollment
Unknown
Registered
2021-09-04
Start date
2021-09-10
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile reflux gastritis

Interventions

bile reflux gastritis group:None
healthy people group:None

Sponsors

Department of Gastroenterology, Shandong University Qilu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Gastroenterology outpatients aged 18 to 70, male or female; 2. Patients with bile reflux gastritis must meet the diagnostic criteria for bile reflux gastritis under gastroscopy: duodenogastric reflux or intragastric cholestasis and gastric mucosal inflammation are clearly observed under gastroscopy; 3. Healthy people need to have superficial gastritis or normal manifestations under gastroscopy; 4. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, liver, kidney and metabolic diseases; 2. Those who abuse alcohol, poison and/or drugs; 3. Have obvious mental and psychological disorders; 4. Those taking PPIs, H2R antagonists, antibiotics and other drugs in the past 2 weeks; 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
gastric mucosa-associated microbiota;—

Countries

China

Contacts

Public ContactYu Yanbo

Qilu Hospital, Shandong University

yuyanbo2000@126.com+86 531 82166670

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026